Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Revolution Medicines, Inc.
Cedars-Sinai Medical Center
Kineta Inc.
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Imperial College London
Massachusetts General Hospital
ImmunoFrontier, Inc.
New Mexico Cancer Research Alliance